AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

Immunomodulatory hybrid bio-nanovesicle for self-promoted photodynamic therapy

Houli Liu1, Yao Lei1, Weidong Nie2, Helin Zhao1, Yuzhu Wu1, Liping Zuo1, Guanghao Wu2, Ruili Yang3( ), Hai-Yan Xie1( )
School of Life Science, Beijing Institute of Technology, Beijing 100081, China
School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, China
School of Stomatology, Perking University, Beijing 100081, China
Show Author Information

Abstract

Thylakoid (Tk) membranes are of unique superiority in photodynamic therapy (PDT) because they not only carry abundant chlorophylls containing photosensitizer porphyrin but also can produce O2. However, the current therapeutic performance of Tk is dramatically limited because of their poor tumor targeting and inefficient O2 production. Here, we report an immunomodulatory bio-nanovesicle of Tk membranes fused with M1 macrophage-derived extracellular vesicles (M1 EV) for efficient PDT of tumors. The hybrid nanovesicle Tk@M1 was prepared by squeezing the Tk membranes of spinach with M1 EV. The systemic study confirmed that Tk@M1 can not only actively accumulate in tumors but also effectively regulate the inactive immune microenvironment of tumors. Such activated “hot” tumors significantly enhance the PDT efficacy of Tk@M1 attributed to the increased O2 from catalase catalyzed decomposition of augmented H2O2, providing a novel idea about constructing natural systems for effective tumor treatment.

Graphical Abstract

Hybrid bio-nanovesicles (Tk@M1) of thylakoid membranes and M1-macrophage derived extracellular vesicles actively target tumors, and then regulate the inactive tumor immune microenvironment by means of the native features of M1 EV and Tk. The activated tumors promote the photodynamic therapy effect of Tk@M1 attributed to the increased O2 from catalase catalyzed decomposition of augmented H2O2.

Electronic Supplementary Material

Download File(s)
12274_2021_4050_MOESM1_ESM.pdf (1.1 MB)

References

【1】
【1】
 
 
Nano Research
Pages 4233-4242

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu H, Lei Y, Nie W, et al. Immunomodulatory hybrid bio-nanovesicle for self-promoted photodynamic therapy. Nano Research, 2022, 15(5): 4233-4242. https://doi.org/10.1007/s12274-021-4050-3
Topics:

1849

Views

20

Crossref

20

Web of Science

20

Scopus

1

CSCD

Received: 15 October 2021
Revised: 04 December 2021
Accepted: 05 December 2021
Published: 02 February 2022
© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2021